KDA
- Current
- Browse
- Collections
-
For contributors
- For Authors
- Instructions to authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
- About
- Editorial policy
Search
- Page Path
- HOME > Search
Letter
- Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (
Diabetes Metab J 2012;36:371-8) - Sheyu Li, Haoming Tian
- Diabetes Metab J. 2013;37(1):81-82. Published online February 15, 2013
- DOI: https://doi.org/10.4093/dmj.2013.37.1.81
- 2,633 View
- 30 Download
- 2 Crossref
-
PDF
PubReader -
Citations
Citations to this article as recorded by
- Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay, Daniel Krewski
Critical Reviews in Toxicology.2018; 48(1): 52. CrossRef - Pioglitazone
SS Jadhav, VK Shivane, AR Lila, TR Bandgar, NS Shah
Journal of Postgraduate Medicine.2014; 60(3): 293. CrossRef
- Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
First
Prev
